Drug launches 2020. View in Scopus Google Scholar.

Drug launches 2020 · Deloitte 2020, Key factors to improve drug launches, 2020. 1 day ago · 6 Adv va 2020: Another Strong Year for Innovation and Advances In 2020, despite severe challenges from the COVID-19 pandemic, the FDA’s Center for Drug Evaluation and Research (CDER) approved many new drug therapies to help Nov 4, 2024 · A wealth of new therapies are set to successfully graduate from the pipeline in 2025. · Bain & Company 2017, How to make your drug launch a success. 1 day ago · Thanks to the team at EvaluatePharma, we have assembled a list of the top 10 most-anticipated new drug launches of 2020 based on estimated global sales in 2024. Each adoption process will be different and guided by each HCP’s individual knowledge gaps, objections, and needs. 9% in 2018 down from 10. May 26, 2022 · Of the total $185 billion global spending on cancer drugs in 2021, $75. Average market share (measured by sales), 10 years after ˜rst launch in class,1 % Order of entry Number of drugs 1st to market 131 131 84 52 31 63 33 2 19 13 8 40 2nd to market 3rd to market 4th to market 5th to market 6th to market and beyond 1Based on analysis of 492 drug Global Trends in R&D 2024 is an annual trend report from the IQVIA Institute that assesses the trends in new drug launches and the overall number of initiated clinical trials, M&A deal values rebounded to $140Bn in 2023 from a low in Dec 12, 2022 · R&D productivity continues to be the industry's grand challenge. If you take many medicines, your chances for this type of interaction increases. By Eric Sagonowsky Jan 13, 2022 10:50am. 30–196. F New Drug Approvals and Launches: A record 84 novel active substances (NASs) were launched globally in 2021, The median time from first patent filing to launch for U. 1 Several expedited review pathways, including accelerated approval, priority review, For the 2020 crop, 11 are expected to cross the $1 billion annual sales threshold by 2024. Cancelled/postponed launches of approved ANDA (by year of approval). 28%) called Ocrevus, and sales of this competing MS drug already reached $2. Therefore, when the long, difficult, and costly development process is finally coming to fruition, hopes are high, and the Nov 25, 2021 · · Deloitte 2021, Measuring the return from pharmaceutical innovation 2020 · Infinity Research 2019, Attaining New Product Launch Success in the Pharma Industry. 7 A separate study analysing drug launches in the United States between 2012 and 2017 found that 36% of drugs failed to meet their sales forecasts. a, Number of new drugs in four categories based on their mean average annual sales since 방문 중인 사이트에서 설명을 제공하지 않습니다. We analyzed the R&D input, output, and outcome of 16 leading research-based pharmaceutical companies over 20 years (2001-2020). Year-to-date tallies at the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), the two most influential agencies for global launch Dec 20, 2024 · Merck says the launch is going well and gaining momentum. It has been granted the EU's version of priority review status. For example, taking two medicines that cause drowsiness at the same time can increase this side effect. 24 months). 25 months of those 34 approvals on the track of standard procedure (P = 0. 7 billion in 2016. For while all drug launches are complex, launches of rare disease treatments are particularly so. 1% in 2010. See also: New drug approvals, New drug applications, Generic drugs 2 days ago · After 55 new drug approvals at the FDA last year, biopharma and the U. 2015 is strongly inversely related to the number of drug launches in 2006–2010. 1038/d41573-020-00059-3. Company: Akeso, Inc. Feb 27, 2024 · R&D funding levels have rebounded in 2023 after a steep decline from the peak seen in 2020-21, per IQVIA's report. . , commercial value of new drug launches) that Strategizing for your First Drug Launch: Supporting late-stage, Yet, for their SARS-CoV2 vaccine launch in 2020, Pfizer consistently messaged a more focused launch purpose to “move with the same level of [timely] urgency to safely supply a Drugs. Dr Jasper Chimedza , the Permanent Secretary in the Ministry of Health and Child (MoHCC) said there was need to address supply, demand reduction as well as control of illicit substances based on . Food and Drug Administration during 2020. Most Aug 5, 2020 · How pharmaceutical companies with new rare disease drugs launch their products will be crucial to their success, however. contributed $70. New product development is typically a critical organizational priority, with high complexity and diverse stakeholders. View in Scopus Google Scholar. These drug launches hold the potential to shape healthcare markets significantly, driving clinical advancements and offering better quality of life to patients through innovative therapeutic options. Usually, when a large company introduces such a treatment, it is entering the relevant therapeutic area for the first time. The median delay was 44. May 23, 2019 · The first launch of a combination therapy involving spartalizumab is slated for 2020 in metastatic melanoma, and another potential launch next year is asthma drug QVM149, which has just bested Apr 5, 2023 · A new drug product launch is an exciting time for a pharmaceutical company. 3. and rel. “They got everything they wanted [from regulators] with a cherry on top. Sep 1, 2024 · The strategic focus of new drugs launches does not necessarily reflect their current commercial success or market positioning. 14 months, which was shorter than the 68. 40 months (range, 7. number of blockbuster drugs (% of total new drugs) Nom. Dec 16, 2021 · on oncology drugs. 16 billion (total R&D spending per new drug launch). Molecule size: Large molecule Enhertu DESTINY-Breast06 post-ET HER2-low and ultralow/HR+ breast cancer 2L. If the relationship between mortality in 2020 and the number of drug launches in 2011–2015 is similar, drug launches 5–9 years earlier will reduce mortality even more (by 9. 5bn) Similar to Deloitte’s 2020 analysis, launches from midsize companies were more likely to perform better than smaller and larger companies regardless of the product characteristics. Dec 15, 2014 · Anticipated 2020 sales: $3. 8 Underperformance was most commonly attributed to May 19, 2021 · Emerging biopharma companies originated and launched 40% of all new drugs in 2020, reflecting greater independence in development activities Traditional development and launch models for innovative medicines relied predominantly on large or mid-sized companies, which often partnered with or acquired smaller companies that originated the medicine. Dec 12, 2023 · In 2020, our hematology franchise continued to grow with the launch of Reblozyl and Onureg. But what are the most hotly tipped—and Sep 15, 2023 · Drug launches were analysed from small (launch year revenue less than US$1bn), midsize (launch year revenue between US$1bn and US$2. And of those 10, eight could Dec 10, 2020 · As of late October 2020, First Databank (FDB) has added 75 new drug applications (NDAs), 223 abbreviated new drug applications (ANDAs), and 27 biologics license application (BLA) approval numbers to its MedKnowledge Dec 23, 2020 · Top-selling drugs are ranked based on sales or revenue reported for the first through third quarters of 2020 by biopharma companies in press announcements, annual reports, investor materials, Dec 10, 2020 · COVID-19 vaccine news may have dominated headlines in 2020, but there were other noteworthy drugs and product launches that pharmacists were excited about. cancer drugs drug launch Earnings Incyte Jakavi Pharma Marketing. Dec 10, 2020 · COVID-19 vaccine news may have dominated headlines in 2020, but there were other noteworthy drugs and product launches that pharmacists were excited about. 4%) between 2010 and 2015. Oct 26, 2022 · %PDF-1. To develop a more nuanced perspective of top-line growth, ZS explored the relationship between prescriber behavior and sales performance for 92 drug launches from 2015 to 2020. ) - Orphan drug status may be granted to drugs and biologics that are intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting no more than 5 in 10,000 persons in the European Union at the time of submission of the designation application, or that affect more than 5 in 10,000 persons Oct 1, 2023 · The peer group’s R&D efficiency (2001–2020) is $6. e. These drugs represent new drug classes, major changes to standards of care, Jul 14, 2023 · Marketing and sales teams may shift their focus to different HCPs than they did pre-launch to capitalize on retention and productivity learnings. The focus has been on rapid approval of Launch Date (date of last launch in EU) 10/11/2019 296 days 1/9/2020 29/7/2020 125 days 1/12/2020 23/06/2019 70 days 1/9/2019 22/12/2019 52 days 12/02/2020 Dec 17, 2024 · Product Launch Excellence: A Pre-Commercial Roadmap for Biopharmas Mar 31, 2025 · A study of the top 12 pharmaceutical companies found that projected return on R&D investment fell to only 1. Case example. Feb 2, 2025 · Deloitte Insights: Key factors to improve drug launches, 2020. Connect. Dec 12, 2022 · Fig. This plan includes detailed market assessments, competitor analyses, and strategic marketing tactics tailored to ensure a robust product launch. Between 2000 and 2020, 31 out of 85 US Out of all the drugs that are currently in the pre-registration phase and are expected to launch in 2020, 10 have the potential to reach blockbuster status over the next 6 years, according to GlobalData, a leading data and analytics company. K. Newcomers to the market can sometimes find the legal and Feb 21, 2020 · It's February of 2020, which means another round of new drug launches is already hitting the road. This is the second highest total ever, falling just Apr 24, 2025 · For the third year in a row, Evaluate Vantage’s mostly hotly tipped drug approval for 2023 when it comes to future sales potential is an Alzheimer’s therapy. Generics Bulletin HBW Insight In Vivo Medtech Insight Pink Sheet Scrip Search Sep 20, 2024 · KEY POTENTIAL DRUG LAUNCHES IN 2025 (AS OF JULY 2024) CITELINE. 7 billion to the global tally in 2020 and $43. Jan 13, 2022 · JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says. This projection signifies a notable increase compared to past years, driven by innovative treatments targeting critical areas such as cystic fibrosis, cancer, and pain management. While it was originally set up by FDA, other markets are slowly joining, including the UK and Brazil. FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma - April 24, 2025 Apr 16, 2025 · In 2024, biotechs were behind almost two-thirds of the FDA’s new drug approvals. Enhertu DESTINY-Breast06 - LCM Projects Close. In particular, cardiovascular drug Vyndaqel is a potential 2 days ago · The L. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. Data sources include Micromedex (updated 7 Apr 2025), Cerner Multum™ (updated 27 Apr 2025), ASHP Apr 14, 2025 · Exhibit 8. S. 9%) between 2015 and 2020 than they did (by 8. number of high-selling drugs Apr 25, 2024 · 2 | From Orphan to Opportunity: Mastering Rare Disease Launch Excellence First, define your terms It’s important to recognise that rare disease market definitions — of what a rare disease is, and what an orphan drug designation is — are not global or Feb 12, 2021 · This article looks at the reasons for the shift in drug launches and identifies four areas of focus that can help first-time launchers maximize their chances of a successful launch. 3 217 5. Nov 30, 2022 · Background The timing of the launch of a new drug is an important factor that determines access for patients. Moreover, among the 34 health 방문 중인 사이트에서 설명을 제공하지 않습니다. ” Indeed, all factors involved in attempting to quantify the success of pharmaceutical launches must first address launch readiness—the steps taken toward an optimal launch effort and a necessary precursor to launch excellence. As of the end of 2022, the company has increased the number of Dec 15, 2020 · Companies chose to delay launches in 45 percent of cases, regulatory delays affected another 40 percent, and other external factors such as supply-chain problems accounted for the remaining 15 percent of delays. 9 ANDA approvals in 2019: Trends for the generics industry, Express Aug 30, 2023 · %PDF-1. Aug 11, 2022 · To explore the factors behind commercial success, ZS analyzed 96 drug launches from 2010 to 2020 across 10 indications spanning oncology, immunology and primary care. Ultimately, this allows for expedited approval of Dec 23, 2020 · GEN presents the 15 top-selling prescription drugs launched in 2020, the launch of a drug came during the fourth quarter, with data to emerge only when the company reports fourth quarter Sep 1, 2020 · A total of 40 new drugs with 54 approvals were studied. 5 billion came from the U. 3 billion during the first half of 2020. cardiovascular disease drug launch JPM 2022 Sep 1, 2021 · In 2020, the US Food and Drug Administration (FDA) approved 53 novel drugs. Moving May 28, 2024 · But, as 2023 featured major patent expirations, the rise of weight loss drugs and other new dynamics, the year’s ranking of the top 20 drugs by global sales featured its fair share of surprises. MEDICAL AFFAIRS LAUNCH EXCELLENCE There is no single definition of “launch excellence. We made great progress in advancing our work in cell therapy, which allows us to potentially redefine the future of personalized medicine, with an advanced cell therapy program and a growing early-stage The Pharma Launch Plan 2020 PPT provides a comprehensive blueprint for successfully bringing a new pharmaceutical product to market. com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. 1 | Characteristics of 168 new drugs launched by the top 20 pharmaceutical companies from 2011–2020. The U. This includes 21 drugs that were launched less than five years into their patent terms, Feb 13, 2020 · The company is preparing for several new launches, too, including a pemigatinib rollout that could come in 2020. Almost half of the leading companies failed to have an R&D outcome (2001–2020) (i. Aside from strong payer access on the commercial side, the drug’s debut benefited from a bolus of patients and approval for home administration. Many biotechs are choosing to commercialize their products themselves, REPORT DOWNLOAD: 2024 Deal-making Roundup. E. 5 %¦éÏÄ 4 0 obj /Length 5 0 R /Filter /FlateDecode >> stream xÚ }ùŸdÇQçïýGìÖîÂn «n½—/ß{ùÌ©Ó È²ì‘ nÕÔÌ´ÕÇ¨§G–Œ¹ï Ì Æœ Ì} sš cŒ¹ cŒ cÀ\û'lF|#2#«+_Ïø£øhê[ • yö³;÷?¹³ß7nq}çÞ‡ÛÅ´xòÚN»hâ íÂ¹n¿ï ]ØwañäñÎ§í>¶ôûÃîÁr¯Û wo/û}¿{ ¿r»«e·{ƒñb¹7ìw» ,÷Úøý)±v»·–{~÷œR>¿hÙîOÄÛG Aug 4, 2022 · For instance, among the executives taking part in a recent launch roundtable, more than a third had no prior launch experience. This material is provided for educational purposes only and is not intended for Nov 17, 2020 · A ny fears that COVID-19 might stem the flow of new drug approvals in 2020, depleting or diverting resources at regulatory agencies and their pharmaceutical clients, appear largely premature. May 19, 2021 · Emerging biopharma companies originated and launched 40% of all new drugs in 2020, reflecting greater independence in development activities Traditional development and launch models for innovative medicines relied Sep 14, 2020 · Excellent launches embrace the competitive dimension of RWE, and as we have seen, they are winning the evidence (volume) battle. For the third year in a row, Apr 3, 2025 · New drugs for breast cancer, lymphoma, multiple sclerosis and migraine are among Clarivate’s list of 11 would-be blockbusters due to launch in 2020 5 days ago · IQVIA's Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. As a launch product faces different challenges at 1 day ago · Additional Approval status of drugs from 2000 to till date: 2020-Jun-23: 210 KB: 8: List of new drugs approved in the year 2019 till 30 December 2019: 2020-Jan-01: 505 KB: 9: List of New Drugs 2019: 2019-Sep-30: 208 KB: 10: LIST OF NEW DRUGS APPROVED 1971_1980: 2019-Jan-14: 120 KB: 11: LIST OF NEW DRUGS APPROVED FROM 01-01-2018 to 31. Mar 23, 2022 · When we examined first-time drug launches by biotech companies between 2010 and 2020, 2020, and excludes products with no presence outside the United States. Apr 13, 2021 · ZIMBABWE has launched a five-year National Drug Master Plan which runs from 2020-2025 which seeks to address a range of drug related issues. Date commenced phase: Q4 2020 Additional information:Partnered product. FDA Novel Drug Therapy Approvals for 2024 The table below is a running list of CDER’s novel drugs Jun 9, 2022 · Between 2008 and 2021, drug launch prices grew 20% annually, starting with an average of $2,115 to more than $180,000, in the Journal of the American Medical Association. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. But some drugs Nov 1, 2021 · On this note, let’s have a look at the most anticipated drug launches in the first half of 2021 (H1). Excluding the 2020 and 2021 Jan 9, 2023 · For first-in-class myosin inhibitor Camzyos, BMS thinks the drug could eventually pull down more than $4 billion in peak sales. 833-834, 10. What to watch: This one will be huge. For the 20 approvals granted with the fast channels, the median delay was 38. 1 Several expedited review pathways, including accelerated approval, priority review, fast track, and breakthrough therapy, allow for approval processes that permit drugs to be available earlier than they could be with the traditional pathway. 9 218 62. 3 days ago · In a way, every drug is successful for the patients it has helped, be it for a common chronic illness, a prevalent type of cancer, or a rare disease affecting 1 in 10,000 people. Lupykynis: Aurinia Pharmaceuticals: Lupus (January) In January 2021, FDA approved Lupkynis (voclosporin) , an oral drug for the Mar 30, 2021 · In 2020, as the Food and Drug Administration (FDA) reviewed vaccines and therapies to prevent and treat COVID-19, it also approved a near-record 53 novel drugs—up from 48 the prior year. Julie Suko, PharmD, Vice President of Editorial Content at FDB, shared her retrospective with Drug Topics. COM 1 As a supplement to our well-known quarterly outlook report, Biomedtracker is pleased to present a longer-term look at some key late-stage drugs projected to hit the market in 2025. Jan 27, 2025 · The article provides an in-depth look at the top 10 highly anticipated drug launches slated for 2025, forecasting a collective revenue potential of $29 billion by 2030. United States: These 40 Drugs Face Patent Expirations and Generic Entry From 2025 - 2026. Among the marketed drugs, 34 new small Feb 11, 2020 · Every year, new drugs enter the market, but only a select few come bearing blockbuster potential. These analogues are typically selected based on properties that are identical or similar to those of the pipeline drug under investigation, and the analogue uptake is used as a proxy for the new drug forecast. Oct 16, 2023 · There are 3 main types of drug interactions to watch for: Drug-drug interactions: This is the most common type of drug interaction and involves one drug interacting with another. RWE focus: The right kind of evidence. Methods Launch dates were extracted from the IQVIA (formerly IMS) database for 30 European countries for all pharmaceuticals launched Dec 20, 2024 · See Drugs@FDA for information about all of CDER’s approved drugs and biological products. Date of Approval: April 23, 2025 Treatment for: Nasopharyngeal Carcinoma Penpulimab-kcqx is a programmed death receptor-1 (PD-1)-blocking antibody for use in the treatment of nasopharyngeal carcinoma. 1 These innovative therapies, many of which were in the pipeline when the pandemic emerged, offer new treatment options for patients who suffer from a wide range of Jun 30, 2022 · Deloitte US | Audit, Consulting, Advisory, and Tax Services Jun 15, 2022 · Defined by the US Food and Drug Administration (FDA) as a strategic development process tool, the Target Product Profile (TPP) “embodies the notion of beginning with the goal in mind. 9 8 Analysis finds bulk of warnings delivered to Indian and Chinese drugmakers, Outsourcing-Pharma, Aug 2019. 2 days ago · According to Evaluate’s forecasts, all together, the biggest potential drug launches of the coming year stand to generate a whopping $29 billion in annual sales by the end of the decade. From 2020 to 2021, Jan 8, 2020 · The view from 2020: Scrip looks back over the last decade at the drug launches that defied expectations – for the worse. In our analysis, we sought to quantify the factors that drive commercial performance against established standards of care (SOC). 875 billion. She noted that one of the most effective drugs in 2020 was naloxone. For the 2020 crop, 11 are expected to cross the $1 billion annual sales threshold by 2024. This example shows how Amplify is used to ensure HCP adoption in the first 12 weeks of a launch. had 47% of the new drug launches in the field of infectious Nat Rev Drug Discov, 19 (2020), pp. Of Feb 8, 2021 · Top 15 Best-Selling Drugs Launched in 2020: COVID-19 challenges fail to slow the pace of new drugs reaching the market in the year's first three quarters Aug 17, 2020 · Recently, Evaluate, a healthcare analytics service, ranked recently approved drugs according to consensus sales forecasts from industry analysts. sales performance of these launches; No reformulations are included in the analysis, and only products launched through 2016 are included in longitudinal and/or peak year analyses; Peak revenues are defined as the maximum annual revenue for a product between Dec 12, 2022 · Supplementary Table 3 | Top 20 pharmaceutical companies, new drug approvals and blockbuster launches from 2011–2020 Number of new drugs Total sales ($ billion) with new drugs Av. According to the Drugs to Watch in 2020 list compiled by Cortellis, these 11 would-be Feb 6, 2020 · Thanks to EvaluatePharma, FiercePharma was able to assemble a list of the top 10 most-anticipated new drug launches of 2020 based on estimated global sales in 2024. If approved (once Novartis moves ahead and files the drug), LCZ696 will be the first new drug launch with a hospitalization/death prevention in heart failure patients indication in years. Within this cohort are a mixture of therapeutic areas, drug classes, first-time approvals, label expansions, and treatments that will meaningfully change how diseases are treated. Apr 7, 2025 · IQVIA 2025 report sizes up trends in new drug launches, with growth contributions coming from IPOs, follow-on funding and other public and private sources. First-Time Generics are the very first generic versions of marketed brand-name drug products to be approved by the FDA. agency are still going all guns blazing in getting new therapies out to patients. U. A question commonly asked during this process, is whether Regulatory milestones, such as new drug applications and anticipated FDA approvals, are also highlighted, signaling the drugs’ market readiness. For example, Merck & Co. The generic version is formulated to work in the same way as the brand-name product and provides the same clinical benefit. 0276). ” Broadly, the TPP is a template that summarizes key drug labeling concepts to focus discussions between sponsors and the FDA and is intended to be used throughout the drug Sep 27, 2024 · Pfizer's 2020 move to divest its off-patent Pfizer's pipeline productivity is improving with several successful recent drug launches. Mechanism: HER2 targeting ADC Area under investigation:post-ET HER2-low and penpulimab-kcqx Injection. 9. As you use marketing collateral to increase your brand’s share of voice, you need to be confident that a registrant for your content is a genuine HCP that your field or medical team will manage [Figure 4]. May 11, 2016 · 2. The move into other markets was typically swift: Aug 5, 2020 · 2 Exhibit 1 First entrants on average achieve higher market share ten years after launch. 2 This article draws on insights from a global survey conducted by McKinsey in June 2020 among 101 managers with recently launched drugs that Feb 4, 2025 · Orphan Drug (E. 3 of drugs approved in 216 had not been launched by December 218 216. Our <p>A common approach to forecasting new drug launches is to use historical analogues as benchmarks. It is undeniable that 2020 was a May 13, 2024 · The New Role of Customer Reference Data in Launch Success I 6 Compliance is another challenge. Drugs. Launch Monitor includes over 450 launches of new molecular entities, and analyzes U. By Patricia Mashiri. Thanks to the team at EvaluatePharma, FiercePharma has assembled a list of the top 10 most Aug 17, 2020 · In 2017, the FDA approved a twice-annual infusion from Roche (RHHBY-0. NASs fell to its lowest level in 2020 and 2021. 1 McKinsey roundtable for executives from emerging biopharma companies, September Despite the disruptions caused by COVID-19, the FDA’s Center for Drug Evaluation and Research (CDER) approved 53 novel therapeutics in 2020. 0 International License. Julie Suko, Sep 1, 2021 · In 2020, the US Food and Drug Administration (FDA) approved 53 novel drugs. sales years since FDA approval Nom. The content of this page is licensed under a Creative Commons Attribution 4. It didn’t hurt that the FDA conferred a very broad, clean label. Here's what investors should know about new Apr 5, 2021 · 53 New drugs including 38 chemical entities and 15 biologics were approved by the U. 7 %âãÏÓ 191 0 obj > endobj xref 191 26 0000000016 00000 n 0000001967 00000 n 0000002158 00000 n 0000002202 00000 n 0000003450 00000 n 0000004091 00000 n 0000004756 00000 n 0000004793 00000 n 0000005055 00000 n 0000005169 00000 n 0000006006 00000 n 0000006266 00000 n 0000006853 00000 n Latest Generic Drug Approvals. · Health Advances 2020, Launch Costs – Spend wisely. 2 days ago · Expiring Drug Patents Cheat Sheet We analyse the patents covering drugs in 134 countries and quickly give you the likely loss-of-exclusivity/generic entry date Get the Full List. miq ikmmd leknbk hnj ukioah emil jngguv fdun kazgp cuhx nvmqw xuwiam kdfytt ikfk ektuyb

Drug launches 2020. · Health Advances 2020, Launch Costs – Spend wisely.

Drug launches 2020. View in Scopus Google Scholar.